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Abstract
Superparamagnetic iron oxide (SPIO) nanoparticles are contrast agents used for magnetic resonance imaging.
Ferucarbotran is a clinically approved SPIO-coated carboxydextran with a diameter of about 45–60 nm. We investigated
the mechanism of cellular uptake of Ferucarbotran with a cell model using the murine macrophage cell line Raw 264.7. We
observed a dose-dependent uptake of these SPIO particles by spectrophotometer analysis and also a dose-dependent
increase in the granularity of the macrophages as determined by flow cytometry. There was a linear correlation between the
side scattering mean value and iron content (P,0.001, R
2=0. 8048). For evaluation of the endocytotic pathway of these
ingested SPIO particles, different inhibitors of the endocytotic pathways were employed. There was a significant decrease of
side scattering counts in the cells and a less significant change in signal intensity based on magnetic resonance in the
phenylarsine oxide-treated macrophages. After labeling with SPIO particles, the macrophages showed an increase in the
production of reactive oxygen species at 2, 24, and 48 h; a decrease in mitochondrial membrane potential at 24 h; and an
increase in cell proliferation at 24 h. We concluded that Ferucarbotran was internalized into macrophages via the clathrin-
mediated pathway and can change the cellular behavior of these cells after labeling.
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Introduction
Superparamagnetic iron oxide (SPIO) nanoparticles with
dextran or carboxydextran coating are magnetic particles that
have been used as a magnetic resonance imaging (MRI) contrast
agent [1]. After intravenous injection, these particles are
recognized by macrophages that reside mostly in the liver, bone
marrow, and spleen [2,3]. SPIO has been used as a liver-specific
contrast agent for detecting primary and metastatic liver tumors
[4]. Ferucarbotran is one of the few SPIO particles that is
approved for the use in clinical medical imaging [4]. Ferucarbo-
tran is composed of iron oxide and has a core diameter of 4.2 nm
and a polymer coating composed of carboxydextran for
prevention of aggregation and sedimentation. The final diameter
of this composite is on average 62 nm. A brief description of this
nanoparticle is listed in Table 1 [5,6]. The carboxyl side chain of
Ferucarbotran makes it easier for it to be conjugated with cell
targeting molecules, such as antibodies or peptides. Different
compositions of the coating can contribute to different levels of cell
uptake efficiency, as shown in human monocytes (macrophage
lineage cells) [6].
Although SPIO particles have been used for stem cell and
immune cell labeling, little is known about their mechanism of
cellular uptake [7,8]. Previously, limited results have revealed that
the cellular uptake mechanism of Ferumoxides (a dextran coated
non-ionic SPIO particle with a diameter of 80–150 nm) into
macrophages is via scavenger receptor type A (SR-A) [9].
Compared to the Ferumoxides, Ferucarbotran is smaller, ionic,
and has a different coating. A complete understanding of the effect
of particle size, surface composition, surface charge, and the
mechanism of internalization is important for the future design of
novel nanoparticles for highly efficient cell labeling. We previously
investigated nanoparticle-labeled macrophages using flow cytom-
etry and observed increased side scattering counts (SSC) when the
cells were treated with an increased concentration of SPIO
particles [10]. In this article, we evaluated the mechanism involved
in macrophage labeling with Ferucarbotran and the change in
cellular behavior that occurred after labeling.
Materials and Methods
Cell culture
The macrophage cell line Raw 264.7 (Culture Collection and
Research Center, Hsin-Chu, Taiwan) has been widely used in the
evaluation of macrophage behavior and nanomedicine [11,12].
These cells were incubated in Dulbecco’s modified Eagle Medium
(DMEM) (Cellgro, Herndon, VA, USA) supplemented with 10%
heat-inactivated fetal bovine serum (FBS), penicillin (50 U/ml),
and streptomycin (0.05 mg/ml). The cells were incubated at 37uC
in 5% CO2. Different SPIO concentrations of Ferucarbotran and
Ferumoxides had been employed in the cellular incubation [6].
Among these, induction of apoptosis was found with $500 mg
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altered by Ferucarbotran concentrations as high as 2000 mg Fe/
mL. For iron content determination, Ferucarbotran was added to
the culture medium for 24 h at concentrations of 0, 1, 3, 10, 30,
and 100 mg Fe/ml, which corresponded to 0, 0.11, 0.33, 1.1, 3.3,
and 11 the times the plasma concentration after intravenous
administration of Ferucarbotran at the clinically suggested dosage
[6].
Flow cytometry detection of SPIO particle uptake
To study the mechanism of SPIO particle uptake, macrophages
were seeded at 1610
5 cells per well in six-well plates and allowed
to attach for 24 h. These macrophages were incubated with
various inhibitors (Sigma-Aldrich, St. Louis, MO, USA), as
described below, and with a suspension of Ferucarbotran
(10 mg/mL) for 4 h. The inhibitors were phenylarsine oxide
(3 mM), cytochalasin D (3 mM), nocodazole (10 mM), filipin (3 ug/
ml), and wortmannin (100 nM) [13]. Treated cells were then
washed three times with phosphate-buffered saline (PBS; 137 mM
NaCl, 2.68 mM KCl, 10 mM Na2HPO4, 1.76 mM KH2PO4,
pH 7.4) and then harvested by trypsinization. After centrifugation,
the cell pellet was washed once and resuspended in PBS
containing 2% FBS solution. The effects of the inhibitors on
cellular SPIO particle uptake were examined using a FACSCa-
libur flow cytometer and CellQuest Pro software (Becton
Dickenson, Mississauga, CA, USA).
Iron content determination
The iron concentration in macrophages was determined as
previously described [6,14]. Briefly, 1610
5 macrophages after a
4 h or 24 h exposure to Ferucarbotran at various concentrations
(0, 1, 3, 10, 30, and 100 mg Fe/ml) were dissolved in 1% sodium
dodecyl sulfate (SDS) buffer. The solution was then examined by
using a spectrophotometer (SpectraMax M5/M5e, Molecular
Devices, CA, USA) at a wavelength of 248.3 nm. The Fe
concentration was determined by comparing the absorption value
of each sample with six standards containing Ferucarbotran with
Fe concentrations of 0, 1, 3, 10, 30, and 100 mg Fe/ml.
Mitochondrial membrane potential determination
The mitochondrial membrane potential (MMP) of macrophages
was determined as previously described [11,15]. Briefly, 1610
5
macrophages were seeded in a 12-well plate for 12 h and
incubated with Ferucarbotran for another 24 h. Cells were
harvested and incubated with 3,39-dihexyloxacarbocyanine
(DiOC6 [3]), a positively charged dye, at 37uC in a humidified
atmosphere of 5% CO2 for 30 min. The cells were then washed,
centrifuged, and resuspended in PBS. The fluorescent intensities of
the cells were measured and analyzed by flow cytometry (BD
Biosciences, Franklin Lakes, NJ, USA). Only living cells were
included in the analysis.
Reactive oxygen species determination
Reactive oxygen species (ROS) production after administration
of iron oxide was measured using a dichloro fluorescein diacetate
(DCFDA) fluorescent probe (Molecular Probes, Eugene, OR,
USA) [16]. Briefly, macrophages were exposed to SPIO particles
at 100 mg Fe/mL for 0, 15, 60, or 120 min and then washed once
with PBS. A total of 1 ml of DMEM and 10 mL DCFDA (10 mM)
were added to each well. The cells were then incubated at 37uC
for 2 h and then washed with PBS three times and harvested. The
fluorescent intensities were measured and quantified by flow
cytometry.
Cell viability assays
Cell viability was evaluated by MTT (3-[4,5-dimethylthiazol-2-
yl]-2,5- diphenyltetrazolium bromide) assay. SPIO particle-labeled
macrophages and unlabeled cells were grown in triplicate in 24-well
plates at 5610
3 cells/well for 24 h. Afterward, MTT was added to
the medium at a final concentration of 0.5 mg/ml, and the cells
were then incubated for 1 h at 37uCi n5 %C O 2. After incubation,
the dark-blue formazan dye generated by the living cells was
proportional to the number of live cells, and the absorbance at
570 nm was measured using a microplate reader (Infinite F200;
Tecan, Ma ¨nnedorf, Switzerland) [17]. MTT data were expressed as
the percentage of the average values of the control cells.
Magnetic resonance imaging
MRI was performed using a clinical 1.5 T MR System (Signa
Excite; GE Healthcare Bio-Science, Piscataway, NJ, USA). The
cell samples were centrifuged and placed in a water tank, and the
tank was then placed in an 8-channel head coil. Two dimension
T2-weighted gradient echo pulse (GRE) sequences were used
(TR/TE=550/15 ms, FA=15). The slice thickness was 1.4 mm
with a 0.03 mm gap, and the field of view (FOV) was 14610.5 cm.
Total scan time was 4 min and 43 sec at a number of 3 excitations
(NEX). Both axial and coronal planes were scanned for
confirmation of the data. The images were then analyzed at a
workstation provided by GE Healthcare (Piscataway, NJ, USA).
Statistical analysis
All experiments were repeated at least twice, and each sample
was measured in triplicate. The intracellular iron concentration
and SSC mean values were compared using Student’s t-test.
Statistical significance was assigned if the p value was less than
0.05. All computations were done using SPSS 10.0 software (SPSS
Inc, Chicago, IL, USA).
Results
SPIO uptake
After either a 6- or 24-h incubation with SPIO particles at
various concentrations, the macrophages exhibited both increased
SSC, as based on flow cytometry, and uptake of iron, as detected
by spectrophotometry (Figure 1). The incubation concentration of
the SPIO particles had a strong influence on the level of
intracellular particle uptake. Incubation for 24 h resulted in a
slight but not significant increase in iron uptake compared to the
Table 1. Physical and chemical properties of Ferucarbotran.
Ferucarbotran Ferumoxytol
Brand Name Resovist Code 7228*
Magnetic properties Superparamagnetic Superparamagnetic
Core composition Fe2O3 and Fe3O4 Fe3O4
Core diameter 4.2 nm 6.76 nm
Coating composition Carboxydextran Modified dextran
Relaxivity R1 (mM21s 21) 7.2 (1.5 T and 37uC) 38
Relaxivity R2 (mM21s 21) 82 (1.5 T and 37uC) 83
Surface charge Ionic Anionic
Size 45–60 nm 17–31 nm
*Code 7228 is the code name in the development pipeline (AMAG
Pharmaceuticals Inc).
doi:10.1371/journal.pone.0025524.t001
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was 18 pg Fe/cell. This occurred at a concentration of 100 mg Fe/
ml SPIO following a 24 h incubation, which was statistically
significant compared to the control.
We further investigated the relation between intracellular iron
content and side scattering mean values (Figure 2). There was a
linear correlation between the side scattering mean value and iron
content (P,0.001, R
2=0. 8048). This finding suggested that flow
cytometry might be a good indicator for determining intracellular
iron content.
Mechanism of uptake
Under flow cytometry, the macrophages pretreated with
phenylarsine oxide exhibited decreased SSC compared to the
control. In contrast, no significant change in SSC was found in the
cytochalasine D, nocodazole, filipin, or wortmannin treated
macrophages (Figure 3). The endocytotic pathway of macrophages
involved in SPIO particle uptake was also confirmed by our MRI
results (Figure 4). Control Ferucarbotran-labeled cells showed a
decreased signal intensity under T2 weighted images, and those
labeled cells pretreated with cytochalasine D, nocodazole, filipin,
or wortmannin demonstrated a similar drop in signal. However,
macrophages incubated with phenylarsine oxide had lower change
in signal intensity compared to these other groups.
Cellular behavior
The evaluation of cellular behavior was performed by MMP
assay, ROS assay, and MTT assay (Figure 5, 6, 7). There was a
dose-dependent decrease in MMP in the cells treated with
Ferucarbotran for 24 h at the concentrations of 1, 10, and
100 mg Fe/mL. The ROS production increased after 2 h and
lasted up to 48 h. We also observed a dose-dependent effect on
ROS production. Macrophages treated with 1 mg Fe/mL of
Ferucarbotran produce less ROS compared to the cells exposed to
100 mg Fe/mL. In regards to the MTT assays, macrophages
labeled with 100 mg Fe/mL Ferucarbotran exhibited a significant
increase in proliferation at 1, 4, and 24 h; however, this change
was not observed at 48 h. Macrophages treated with 1 and 10 mg
Fe/mL did not show any change in cell proliferation until the 24 h
time point.
Discussion
SPIO particle uptake
The findings in this study illustrated the dose-dependent
manner of SPIO particle uptake at lower SPIO concentrations
(1 to 100 mg Fe/ml), which is characteristic of endocytotic
phenomenon in cells. These findings are also compatible with
the results observed when peritoneal macrophages are treated with
dextran-coated SPIO particles [9]. However, a time-dependent
manner of intracellular SPIO particle uptake was not seen in this
study. Dose- and time-dependent SPIO particle uptake in
macrophages has been reported from 30 min to 6 h (at 100 mg
Fe/mL) and at higher concentrations ranging from 30 to 1000 mg
Fe/mL during a 1 h incubation [18]. In this previous study, the
iron uptake of macrophages approached a constant level with a
Figure 1. Iron concentrations in macrophages treated with SPIO particles. The amount of SPIO particle uptake by macrophages was
measured using a spectrophotometer. Data are presented as mean 6 SEM, n=3. The basal iron content (of the control macrophages) was subtracted
from the values. The incubation concentration of SPIO has a strong influence on the amount of particle uptake. There was some (but not significant)
increase in intracellular SPIO particle uptake following a long incubation period (24 h) compared to a shorter one (6 h). The maximum particle uptake
was observed at 100 mg Fe/ml SPIO, which was statistically significant when compared to the control.
doi:10.1371/journal.pone.0025524.g001
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with .700 mg Fe/mL after a 1 h incubation period. Therefore,
the saturation of iron uptake after a .200 min incubation period
could explain why there was only a minimal increase in iron
uptake after a 24-hr incubation in this current study. This time-
dependent saturation suggested that a prolonged incubation is not
necessary for improving the amount of iron uptake. Besides, under
physiologic conditions, intravenously administered Ferucarbotran
has a short half-life of about 3.9–5.8 min for the initial fast phase
(accounting for about 80% of the initial concentration) and about
2.4–3.6 h for the second phase. Furthermore, a prolonged
exposure of macrophages to SPIO has been shown to be cytotoxic
[18,19]. Therefore, to avoid unnecessary side effects, an
appropriate selection of incubation period should be made.
Our data revealed a significantly higher cell iron content when
the cells were treated with carboxydextran-coated SPIO particles
compared to previous results using dextran-coated SPIO particles.
Although different measuring methods (spectrophotometer versus
inductively coupled plasma atomic emission spectroscopy) and cell
types (macrophage cell line versus peritoneal macrophages) were
used in these studies, our inference is supported by previous results
[6] that revealed a 2–3 fold increase in SPIO particle uptake in the
carboxydextran group relative to the dextran group.
The increase in iron uptake correlated with an increase in SSC
as measured by flow cytometry. This finding was consistent with
Figure 2. Linear correlation between iron content, as determined using a spectrophotometer, and the mean value of side scattering
counts (SSCs), as measured by flow cytometry. Basal iron content and SSC were subtracted. There was a strong correlation between these two
factors (P,0.001, R
2=0.8048).
doi:10.1371/journal.pone.0025524.g002
Figure 3. The endocytotic pathway of SPIO particle uptake in
macrophages was measured by SSCs via flow cytometry after
the cells were treated with different endocytotic inhibitors.
There was a left shift in the cell distribution following treatment with
the clathrin inhibitor phenylarsine oxide prior to SPIO particle
incubation. The other inhibitors tested showed no effect on cellular
granularity. This finding suggested that the clathrin receptor plays a
major role in the mechanism of cellular uptake of SPIO particles.
doi:10.1371/journal.pone.0025524.g003
Figure 4. MRI of macrophages treated with different endocy-
totic inhibitors prior to SPIO particle uptake. (A) Coronal view
and (B) axial view under T2 weighted scanning protocol. Cells were
centrifuged to the bottom of the test tube and imaged as dark signals.
The coronal view and axial view of these cells are consistent. There was
a drop in signal intensity in the cells treated with Ferucarbotran and
inhibitors, including cytochalasin D (CytD), nocodazole (Noco), filipin,
and wortmannin (Wort). In contrast, the signal intensity of the cells
treated with phenylarsine oxide (PAO) revealed no loss in signal
intensity.
doi:10.1371/journal.pone.0025524.g004
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increased granularity when the cells ingest these nanoparticles.
There are advantages of measuring cells with flow cytometry
when compared to spectrophotometer or inductively coupled
plasma mass spectrometry. First, flow cytometry measures the cell
content without physical damage to the cells, which can occur
when using either a spectrophotometer or ICP-MASS. As such,
cell morphological data can subsequently be acquired when flow
cytometry is used. Second, with flow cytometry, many other kinds
of cell data (e.g., individual cell diameter) can also be obtained.
Third, individual cell data can be combined for statistical analysis
when the targeted cells are heterogeneous. Thereafter, we propose
this method might be used for semi-quantitation of internalization
of nanoparticles by cells.
Mechanism of uptake
Evidence indicates that lysosomal metabolism takes place after
internalization of SPIO particles into cells [1,20,21,22]. Endocy-
tosis of foreign materials can be divided into phagocytosis for
larger foreign materials and pinocytosis for soluble material or
nanoparticles. Pinocytosis can be subdivided into clathrin-
mediated endocytosis (100–150 nm), caveolae (50–80 nm), and
macropinocytosis (500–2000 nm). Phagocytosis occurs in special-
ized cells when the foreign materials are larger than 750 nm
[23,24]. The major route for endocytosis is clathrin-dependent
endocytosis, which is found in virtually all cells. Ferucarbotran is a
nanoparticle, and its hydrodynamic size could be moderately
larger with increasing SPIO concentration (8162.05 nm at
100 mg Fe/ml) [25]. Therefore it is possible that Ferucarbotran
is internalized by cells via the pinocytosis pathway.
To determine which endocytotic pathway is involved when
macrophages encounter carboxydextran-coated SPIO particles,
several inhibitors related to different endocytotic pathways were
incubated separately with macrophages prior to SPIO treatment.
These inhibitors included cytochalasine D, which blocks actin
dependent process such as macropinocytosis; nocodazole, which
inhibits microtubule function involved in intracellular vesicle
trafficking; phenylarsine oxide, which inhibits the clathrin-
mediated endocytotic pathway; filipin, which disturbs caveolae
pathways; and wortmannin, which interferes with phosphoinositol
3-kinase involved in macropinocytosis.
Despite that the hydrodynamic size of Ferucarbotran is
relatively small (8162.05 nm at 100 mg Fe/ml), our results
revealed the internalization of carboxydextran coated and ionic
particles by macrophages occurred via the clathrin-mediated
pathway. It is believed that the clathrin receptor contributes to
internalization of many kinds of nanoparticles [13]; however, the
correlation between SPIO factors (such as size, coating, and
surface charge) and the endocytotic pathways is not well
understood. Further evaluation of different SPIO particles of
various sizes or coatings and their interaction with a particular cell
type would clarify these important relationships.
The MRI findings in this study were consistent with the flow
cytometry data. The SSC measurements obtained by flow
cytometry not only provided information related to the intracel-
lular uptake of SPIO particles, but it also imply of the efficacy of
the MRI signal production of the labeled cells.
Cellular behavior
Our observations suggested that the initial degradation of these
particles began within days, since there was an apparent elevation
in both ROS and MMP as early as 24 h. It has been reported that
no increase in ROS occurs in mesenchymal stem cells, HeLa cells,
or macrophages when they encounter dextran-coated SPIO
particles. However, fluctuations in baseline ROS production
during different time points makes the data difficult to interpret
[16]. The discrepancy between our results and others might be
due to the different cell lines used. The macrophages we used
exhibit strong phagocytic, migratory, and cytokine secretion
behaviors, which indicated their active role in the eradication of
foreign materials and invading organisms [11]. Consequently, the
degradation of SPIO particles in these macrophages is likely very
active and fast compared to other cells. Similar to that observed in
mesenchymal stem cells, the increased proliferation of macro-
phage at 24 h of incubation may have been due to Ferucarbotran
diminishing intracellular H2O2 via its intrinsic peroxidase-like
activity and also accelerated cell-cycle progression, which may
have been mediated by the free Fe released following lysosomal
Figure 5. The MMP of macrophages treated with SPIO particles
was measured by fluorescent intensity of the FL-1 channel.
There was a leftward shift of the fluorescent intensity after the cells had
ingested the SPIO particles, and this response occurred in a dose-
dependent manner.
doi:10.1371/journal.pone.0025524.g005
Figure 6. Flow cytometry measurement of ROS production in
macrophages after SPIO particle uptake at different time
points. The intensity of the fluorescence of the FL-1 channel was
linearly correlated to ROS production. ROS increased when the cells
were exposed to SPIO particles after 2 h, and this effect lasted up to
48 h. There was also a dose-dependent response when the cells were
incubated with SPIO particles for longer periods, indicating that ROS
production is related to particle loading.
doi:10.1371/journal.pone.0025524.g006
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regulators of the cell cycle [17].
The maintenance of the MMP is crucial for energy production
in the form of ATP synthesis. The loss of MMP increases the
release of cytochrome c and triggers a series of intracellular
events, which ultimately result in apoptosis. Thus, loss of MMP is
usually considered an early indicator of apoptosis [26]. Our study
revealed that at 10 mg Fe/mL (equivalent to the plasma
concentration following intravenous administration of Ferucar-
botran) there was a mild decrease in the MMP and a larger
decrease at 100 mg Fe/mL (Figure 5). The MTT assays revealed
no significant toxicity in the Ferucarbotran-labeled macrophages
at the various concentrations up to 48 h (Figure 7). In a previous
study the induction of apoptosis was only observed in monocytes
treated with $500 mg Fe/mL of Ferumoxides, but this did not
occur in those cells treated with Ferucarbotran up to 2000 mg
Fe/mL [6]. However, delayed cell death was shown in
macrophages treated with Ferucarbotran [19]. Although there
is the concern of cytotoxicity with SPIO and/or ultrasmall
superparamagnetic iron oxide (USPIO) particles toward macro-
phages, especially after prolonged exposure, such processes could
likely be antagonized by use of a therapeutic radical scavenger
[18,19].
Because of their smaller size, USPIO particles accumulate in the
reticuloendothelial system much slower than SPIO particles,
which results in a longer plasma half-life. While SPIO particles
mostly accumulate in the reticuloendothelial system, USPIO
particles can enter into the interstitial space from capillaries by
transcytosis and then into the lymph nodes via the lymphatic
vessels [27]. Different cellular uptake efficiencies between SPIO
and USPIO particles have also been previously observed [6]. It
has also been shown that prolonged exposure to USPIO particles
results in decreased cell viability in macrophages [18,19]. Given its
smaller particle size, different charge, and distinct surface
properties (coating), it is possible that the cellular uptake of
USPIO particles occurs via a different endocytosis pathway (e.g.,
caveolae); however, this requires further verification in future
studies.
In vivo cell tracking
Macrophage/monocyte labeling for in vivo cell tracking could
be potentially applied to specific targeting of inflammatory
processes, such as tumor localization, atherosclerotic plaques, or
infections. Several possible noninvasive approaches including
optical imaging, nuclear imaging, and MRI have been reported
[28,29,30,31,32,33,34,35,36,37]. Though nuclear imaging has
good sensitivity, the use of radionuclides introduces potential
radiation damage to the cells and the overall spatial resolution is
relatively poor. Optical imaging is highly sensitive, inexpensive,
and radiation free. This method has been successfully used for
targeting the peritumoral inflammatory response in a murine
model [37]; however, many cyanine fluorescent dyes are cytotoxic,
and their fluorescence can not penetrate soft tissues enough to be
detected by optical sensors. That is, if the imaging target is deep in
the human body, it is unlikely to be detected with a small dose of
fluorescent dye. Compared to other techniques, the sensitivity of
MRI is not as good as nuclear or optical imaging; however, MRI
has outstanding spatial resolution, soft tissue contrast, and signal-
to-noise ratio (SNR). Many approaches, including development of
novel paramagnetic materials, intracellular labeling, or amplifica-
tion of signals produced by contrast mediums, have been
investigated. For example, polymerization of paramagnetic
substrates has been proposed as an MR signal amplification
technique [38], and strong MR signal enhancement by a threefold
increase in relaxivity makes it possible to identify cell surface
receptor expression in vitro. It is also possible to use this technique
in conjunction with SPIO or USPIO particles to augment the MR
signal for identification of different molecular targets in vivo;
however, this method could change the endocytosis pathway
because of the significant increase of the size of the polymer.
Further investigation of the mechanism of cellular uptake and the
evaluation of biocompatibility are necessary in future studies.
Limitations
Currently, Ferucarbotran was not on market since 2009 due to
marketing strategy; thus, access to this particular iron oxide
compound is limited. However, its superior labeling efficiency and
Figure 7. Macrophages were incubated in the absence (control) or presence of 1, 10, and 100 mg/ml of SPIO particles for 1, 4, 24,
and 48 h. The effect of SPIO particles on cell viability was determined via MTT assays immediately after incubation. Data are expressed as the mean
and error of three determinations, with each assay performed in triplicate. Dunnett’s test treats one group as a control and compares all other groups
against it. *p,0.05.
doi:10.1371/journal.pone.0025524.g007
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for cellular imaging.
Conclusions
The endocytotic mechanism of SPIO uptake into macrophage
was determined to be via the clathrin-mediated pathway. Further
development of nanoparticles targeting the clathrin receptor may
increase the efficiency of this cell labeling method. Moreover, we
observed significant cellular changes in macrophages after SPIO
particle labeling. Finally, we developed a strategy for evaluating
cellular uptake of SPIO particles by measuring SSC using flow
cytometry, which demonstrated a high correlation with the results
of both spectrophotometric and MRI methods.
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